It has been proven that Xeloda is just as effective as infusional 5FU (the pump). You are right - they are essentially the same drug, but there are differences because of the way the 5FU gets into your system.
Infusional 5FU is pumped directly into your blood and therefore throughout your body, which is how it gets to the tumor. Xeloda is taken orally and metabolized into 5FU inside your body (through your liver and then inside the tumor itself). With infusional 5FU, more 5FU gets into your body, but with Xeloda, more 5FU makes it into the tumor.
Because the 5FU it doesn't get pumped through your blood, Xeloda doesn't affect the rest of your body as much as infusional 5FU. It makes sense because of course the 5FU is poison, so the less you can have throughout your body means less "poisoning" of the rest of your body. That is why the biggest "plus" for Xeloda is that, other than hand & foot syndrome, the side effects are fewer and less severe for most people on Xeloda than for those on infusional 5FU.
The only major problem with Xeloda side effects is that there is greatly increased incidence of hand & foot syndrome (60% of patients on Xeloda had this vs. 9% on 5FU), but almost all other side effects showed a pretty significant improvement on Xeloda. You have less of chance of the following with Xeloda:
- nausea
- diarrhea
- vomiting
- alopecia (hair loss)
- stomatitis (mouth sores)
- neutropenia (low white blood count)
You have about the same chance of having fatigue, lethargy, abdominal pain, astehnia (feeling of weakness), or constipation. Those aren't all of the issues or the differences, but I would say that there is DEFINITELY plenty of evidence that you can pretty much pick which one you want to do. If your doctor is "leaning" towards infusional, I would ask to see the data s/he is relying on in making that decision. Otherwise I would say that probably it is because infusional 5FU has been around a little bit longer, or - and I hate to suggest this - but it is true that some doctors lean towards the infusion because it is more lucrative for their practice than Xeloda, or possibly because they are behind the times and don't know that studies have shown that Xeloda is just as good.
Honestly if I were making the decision, I would probably choose to do the Xeloda regimen. Check with your insurance company to make sure they will cover it (they absolutely should, but double check anyway!). Xeloda is easier (yeah for taking pills at home!) and cheaper and easier to administer. Although the odds are that you will have to deal with hand and foot syndrome, you will also have a much better chance of avoiding some other nasty side effects without giving up anything in terms of how well your treatment works.
Hannah
p.s. Do keep an eye on advances with Xeloda - there have been studies in patients with metastatic disease that show that Xeloda gets a better reponse than infusional 5FU (though not better survival, if that makes sense). Keep in mind that it took four years after Xeloda was indicated for stage IV disease (2001) to get it approved as first-line treatment for stage III (2005). Also, it was only a few years ago that patients got bolus 5FU instead of the pump - so new things are happening all the time.
Hannah K. Vogler
Co-Founder, The Colon Club
cousin of Amanda Sherwood Roberts
dx 1/99 Stage III at age 24
died January 1, 2002 at age 27